Anavex, Cassava Sciences, And Panax Ginseng: Seeking Agents To Modify Alzheimer's Disease
Seeking Alpha,
Follow Summary Sigma-1 receptor agonists such as Anavex's blarcamesine, Aricept, and possibly Cassava Sciences's simufilam may…
Follow Summary Sigma-1 receptor agonists such as Anavex's blarcamesine, Aricept, and possibly Cassava Sciences's simufilam may…
Las personas que viven con demencia realizan un gran esfuerzo mental solo para cumplir con su rutina diurna.
Summary Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the…
Summary Blarcamesine, Aricept, and most probably simufilam are sigma-1 receptor agonists.